| GDH | glucose dehydrogenase; glutamate dehydrogenase; glycerophosphate dehydrogenase; glycol dehydrogenase... |
|---|---|
| XDH | xanthine dehydrogenase |
| Xan | xanthine |
| XDP | xanthine diphosphate; xeroderma pigmentosum |
| XMP | xanthine monophosphate |
| X-XO | Xanthine-xanthine oxidase |
|---|---|
| XD | Xanthine dehydrogenase |
| XDH | Xanthine dehydrogenase |
| MIX | 1-Methyl-3-isobutyl-xanthine |
| 1-MX | 1-methyl xanthine |
| xanthine dehydrogenase | <enzyme> An enzyme that catalyses the oxidation of xanthine in the presence of NAD+ to form urate and NADH. It acts also on a variety of other purines and aldehydes. Chemical name: Xanthine:NAD+ oxidoreductase Registry number: EC 1.1.1.204 (12 Dec 1998) |
|---|
| desulfo xanthine dehydrogenase | <enzyme> Naturally occuring inactive form of xanthine dehydrogenase Registry number: EC 1.1.1.- (26 Jun 1999) |
|---|---|
| methyl xanthine | <chemical, drug> Naturally occurring purine alkaloids such as theobromine, theophylline and caffeine (trimethyl xanthine). They inhibit cAMP phosphodiesterase and thus cause an increase in the intracellular cAMP concentration. (18 Nov 1997) |
| xanthine | <biochemistry> A purine, the starting point for purine degradation. Its methylated derivatives (theophylline, theobromine, caffeine) are potent cAMP phosphodiesterase inhibitors. (18 Nov 1997) |
| xanthine alkaloids | Alkaloids, which contain xanthine as their nitrogenous base. (12 Dec 1998) |
| xanthine bronchodilator | <pharmacology> A group of medications that work by a common mechanism to effect bronchodilation (open up air passages) in the lungs. Used in the treatment of asthma and related conditions. Examples include: theophylline, aminophylline and dyphylline. (27 Sep 1997) |
| xanthine nucleotide | The monophosphoric ester of xanthosine. An intermediate in GMP biosynthesis. Synonym: xanthidylic acid, xanthine nucleotide, xanthylic acid. (05 Mar 2000) |
| xanthine oxidase | <enzyme> Dehydrogenases involved in conversion of hypoxanthine to xanthine and xanthine to uric acid, as the final catabolism of purines. Deficient in the human disease xanthinuria. (18 Nov 1997) |
| xanthine ribonucleoside | 9-beta-d-ribosylxanthine;the deamination product of guanosine (O replacing -NH2). Synonym: xanthine ribonucleoside. Abbreviation: Xao (05 Mar 2000) |
| hypoxanthine-guanine-xanthine phosphoribosyltransferase | <enzyme> From tritrichomonas foetus; in contrast to EC 2.4.2.8, this enzyme also uses xanthine as substrate; mw 24 kD Registry number: EC 2.4.2.- Synonym: hgxprtase (26 Jun 1999) |
| acetaldehyde dehydrogenase | <enzyme> Works with both nad and nadp Registry number: EC 1.2.1.5 Synonym: aldehyde dehydrogenase (NADP+), naho gene product (26 Jun 1999) |
| acetoin dehydrogenase | <enzyme> An enzyme that catalyses the conversion of acetoin to diacetyl in the presence of NAD. Chemical name: Acetoin:NAD+ oxidoreductase Registry number: EC 1.1.1.5 (12 Dec 1998) |
| acetol dehydrogenase | <enzyme> Forms methylglyoxal; uses nad+ Registry number: EC 1.1.1.- Synonym: 1-hydroxyacetone dehydrogenase (26 Jun 1999) |
| acyl-ACP dehydrogenase | enoyl-ACP reductase (NADPH) |
| acyl-CoA dehydrogenase | <enzyme> See also records for specific fatty acyl groups which have full EC nomenclature number; electron-transferring flavoprotein system reducing ubiquinone and other acceptors; formerly EC 1.3.2.2 Registry number: EC 1.3.99.3 Synonym: fatty-acyl CoA dehydrogenase, palmitoyl-CoA dehydrogenase, short-chain acyl-CoA dehydrogenase, acyl-coenzyme a dehydrogenase, lauroyl-CoA oxidase (26 Jun 1999) |
| acyl-CoA dehydrogenase (NADPH+) | Enzyme catalyzing the reversible reduction of enoyl-CoA derivatives of chain length 4 to 16, with NADPH as the hydrogen donor, forming acyl-CoA and NADP+. Synonym: enoyl-CoA reductase. (05 Mar 2000) |
Synonyms : Purine Hydroxylase I, Dehydrogenase, Xanthine, Hydroxylase I, Purine, I, Purine Hydroxylase
| xanthine dehydrogenase |
[EC 1.1.1.204] an enzyme of the oxidoreductase class that catalyzes the hydroxylation of xanthine or hypoxanthine to urate, using NAD+ as an electron acceptor. The enzyme is a molybdoflavoprotein with a bound FAD and two iron-sulfur centers. Under certain conditions the enzyme is converted to a form that can reduce molecular oxygen and is called xanthine oxidase. Deficiency of enzyme activity, due to isolated defect in the enzyme or to molybdenum cofactor deficiency (q.v.), results in xanthinuria and deposition of xanthine calculi.
출처: www.mercksource.com/pp/us/cns/cns_health_library.j...
|
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|